Battery Ventures, a global, technology focused investment firm, has acquired LI-COR Biosciences, an a specialist in highly engineered instrumentation systems for environmental research, agriculture, drug discovery, protein research and therapeutics development.
As part of the acquisition, current LI-COR Chief Executive Greg Biggs, the son of co-founder Bill Biggs, will transition to an advisory role. Thomas Reslewic, a current Battery executive-in-residence who previously served as group president for two business units within Teledyne Technologies, will become CEO.
